These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3457630)

  • 1. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.
    McCormick KJ; Panje WR
    Cancer Immunol Immunother; 1986; 21(3):226-32. PubMed ID: 3457630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
    Balch CM; Dougherty PA; Tilden AB
    Ann Surg; 1982 Dec; 196(6):645-50. PubMed ID: 6216863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy.
    Maca RD; Panje WR
    Cancer; 1982 Aug; 50(3):483-9. PubMed ID: 7093891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
    Balch CM; Dougherty PA; Cloud GA; Tilden AB
    Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins.
    Berlinger NT
    Laryngoscope; 1984 Nov; 94(11 Pt 1):1407-10. PubMed ID: 6593559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
    Goodwin JS; Messner RP; Peake GT
    J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses.
    Lapointe H; Lampe H; Banerjee D
    Otolaryngol Head Neck Surg; 1992 Feb; 106(2):149-58. PubMed ID: 1738546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
    Tilden AB; Balch CM
    Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of flurbiprofen and indomethacin on the mitogenic response of human peripheral mononuclear cells.
    Jawad AM; Rogers HJ
    Immunopharmacology; 1984 Feb; 7(1):59-67. PubMed ID: 6585353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of indomethacin on T lymphocyte stimulation.
    Kingston AE; Ivanyi J; Kay JE
    Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of indomethacin and interleukin-2 on the proliferation of lymphocytes from patients with lung cancer.
    Maca RD; Burford JG; Taylor RT
    J Clin Immunol; 1985 May; 5(3):158-65. PubMed ID: 3874210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer.
    Blomgren H; Hammarström S; Wasserman J; Petrini B
    Radiother Oncol; 1986 Oct; 7(2):141-5. PubMed ID: 3466235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.
    Goodwin JS; Messner RP
    J Clin Invest; 1979 Aug; 64(2):434-9. PubMed ID: 457862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.
    Wanebo HJ; Riley T; Katz D; Pace RC; Johns ME; Cantrell RW
    Cancer; 1988 Feb; 61(3):462-74. PubMed ID: 2962730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
    Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
    Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
    Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong suppression by mononuclear leukocytes from cord blood of human newborns on maternal leukocytes associated with differences in sensitivity to prostaglandin E2.
    Johnsen SA; Olofsson A; Gréen K; Olding LB
    Am J Reprod Immunol (1980); 1983; 4(1):45-9. PubMed ID: 6226208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prostaglandin-mediated suppressive activity of cord as compared to maternal or other adult adherent cells in OKT3 antibody-induced proliferation.
    Papadogiannakis N; Johnsen SA; Olding LB
    Cell Immunol; 1986 Aug; 101(1):51-61. PubMed ID: 2943416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis.
    Gordon D; Henderson DC; Westwick J
    Br J Pharmacol; 1979 Sep; 67(1):17-22. PubMed ID: 387146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.